Jubilant Pharmova P/E Ratio
Jubilant Pharmova (JUBLPHARMA) P/E ratio is 46.5 (High), EPS (TTM) ₹25.15, current price ₹1065.40 on NSE vs historical average P/E of 19.63 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Also explore Jubilant Pharmova share price performance to track price trends across different timeframes.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
JUBLPHARMA P/E Ratio — Valuation Signal & Historical Context
Jubilant Pharmova P/E 46.5 vs historical average 19.63, range 9.61–39.54 — signal: Overvalued.
- Stock appears overvalued with PE of 46.5, suggesting caution for new investments
- Current PE is 136.9% above historical average
- Trading at discount to sector average PE of 56.85
Jubilant Pharmova P/E Ratio Historical Trend
JUBLPHARMA annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 46.5 vs historical average 19.63. For live price, revenue and the complete fundamental profile, see JUBLPHARMA share price screener.
JUBLPHARMA Historical P/E Ratio — EPS, Year-End Price & Valuation
Jubilant Pharmova annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 39.54 | 27.31 | ₹1079.90 | NSE | High |
| 2021 | 23.87 | 35.69 | ₹851.80 | NSE | Moderate |
| 2020 | 9.61 | 55.4 | ₹532.65 | NSE | Low |
| 2018 | 14.62 | 53.18 | ₹777.60 | NSE | Low |
| 2017 | 15.19 | 40.94 | ₹621.95 | NSE | Moderate |
| 2016 | 14.93 | 28.06 | ₹419.05 | NSE | Low |
JUBLPHARMA vs Healthcare Peers — P/E Ratio Comparison
Jubilant Pharmova P/E 46.5 vs Healthcare average 56.85, median 31.66 — range 1.99–747.21.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |